Currently viewing the tag: "Myriad Genetics"

The Supreme Court issued its decision in the closely watched Alice Corp. v. CLS Bank case on June 19. The result? In an opinion that seemed to follow naturally from the Court’s precedent in Bilski v. KapposMayo Collaborative Services v. Prometheus Laboratories, Inc., and Association for Molecular Pathology v. Myriad Genetics, Alice garnered [...]

Continue Reading

What Do You Think About Patent Subject Matter Eligibility?

On Friday, January 24th, JETLaw will host its symposium on patent-eligible subject matter, Patents 101: From Computer Code to Genetic Codes. (Details below.) Should courts care whether patented processes are implemented in software? Should software be considered unpatentable as an “algorithm”? Should any [...]

Continue Reading

Monday Morning JETLawg

On June 17, 2013 By Bradlee Edmondson

In the Ninth Circuit, Google argues that the Wiretap Act does not prohibit interception of unencrypted wireless transmissions. The Supreme Court unanimously rules in Myriad that isolated DNA is not patentable, while cDNA is. [H/T PatentlyO; SCOTUSBlog] Monsanto keeps farmers who were worried about inadvertent infringement out of court. [...]

Continue Reading

The United States District Court for the Southern District of New York faced a difficult question at the intersection of law and biotechnology last month: can one patent nature? On Monday, March 29, United States District Court Judge Robert W. Sweet said no, and invalidated seven patents related to the BRCA1 and BRCA2 genes, the [...]

Continue Reading